Alfasigma gains neuro treatment; BridgeBio offers $550M in notes
Alfasigma gains neuro treatment; BridgeBio offers $550M in notes
Alfasigma gains neuro treatment; BridgeBio offers $550M in notes
A rolling strip of the companies, platforms, CROs and device makers that show up across the coverage.
Open about page